News

Daily Jang17h
Zevaskyn receives FDA approval for rare, genetic skin disorder
The U.S. Food and Drug Administration has approved Zevaskyn for patients suffering from rare, genetic skin disease recessive ...
PMLive19h
FDA approves Abeona’s epidermolysis bullosa gene therapy Zevaskyn
The US Food and Drug Administration (FDA) has approved Abeona Therapeutics’ Zevaskyn (prademagene zamikeracel) for use in ...